BioIVT adds transporter assay products and services to its ADME-Toxicology portfolio with the acquisition of Optivia Biotechnology – a deal which aligns with the company’s efforts to support drug safety and efficacy, says VP.
Articles comparing CEO salaries are ten-a-penny at outsourcing publications these days as they use readily available data, are quick to compile and – to be frank – generate the strong web traffic that advertisers love.
The US Food and Drug Administration (FDA) has outlined a new draft
plan designed to better enable it to flex its postmarketing muscle
which will significantly increase the number of employees that
focus on drug safety issues and post-market...